サマリー

世界のコレラワクチン市場規模は、2022年に4.9百万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に11.1%の成長率（CAGR）を示し、2028年までに920万米ドルに達すると予測しています。

コレラは、汚染された食べ物や水を通して広がる細菌感染による腸の病気です。激しい下痢、脱水、腹痛、発熱、心拍数の上昇、皮膚の弾力性の低下、低血圧、筋肉のけいれん、口の中、喉、鼻、まぶたなどの粘膜の乾燥などを引き起こします。現在、世界的に公衆衛生上の脅威となっており、ワクチンによって予防することが可能です。コレラワクチンは、生きたコレラ菌を体内で少量暴露することで、病気に対する免疫の発達を助けるものです。経口投与、皮内または筋肉内注射で体内に投与することができます。

コレラワクチンの市場動向
衛生環境の悪化に起因するコレラの蔓延は、市場を牽引する主要な要因の1つです。また、世界中で農業や花卉栽培に汚染された水を使用することが増加しています。これは、個人の多忙なライフスタイルに起因するストリートフードやファーストフードの消費の増加とともに、市場の成長を後押ししています。さらに、下水や工場廃棄物が湖や川に流されることで、水質汚染も深刻化しています。その結果、人々は汚染された魚介類を摂取するようになり、コレラの蔓延を招いています。さらに、非政府組織（NGO）のイニシアティブによるコレラに対する意識の高まりや、ワクチンで予防できる病気を減らすために各国政府が導入した数多くの予防接種プログラムが、市場にプラスの影響を及ぼしています。さらに、主要な市場関係者は、より効率的で費用対効果の高いコレラワクチンを提供するために研究開発（R&D）活動に幅広く投資しており、これが市場の成長を促進すると予測されます。

主要な市場セグメンテーション
IMARC Groupは、コレラワクチンの世界市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、ワクチンの種類、製品、エンドユーザーに基づいて市場を分類しています。

ワクチンタイプ別構成比：

リコンビナントBサブユニットを含む全細胞V. Cholerae O1
キルドオーラルO1、O139

製品別構成比：

デュコラル
シャンチョル
ヴァクスコラ
EuvicholとEuvichol-Plusについて
その他

エンドユーザー別構成比：

病院・診療所
研究・学術研究所
その他

地域別構成比：

北アメリカ
ユーエスエー
カナダ
アジア太平洋
中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中近東・アフリカ

競争環境：
アステラス製薬、Celldex Therapeutics Inc.、Avant Immunotherapeutics Inc.、Emergent BioSolutions Inc.、Eubiologics Co.Ltd.、ジョンソン・エンド・ジョンソン、Merck & Co.Inc、Pfizer Inc.、PharmaChoice Canada Inc、Sanofi S.A.、武田薬品工業株式会社、Valneva SEです。

本レポートで回答した主な質問
世界のコレラワクチン市場はこれまでどのように推移し、今後数年間はどのように推移するのでしょうか？
COVID-19は世界のコレラワクチン市場にどのような影響を与えたか？
主要な地域市場とは？
ワクチンの種類に基づく市場の内訳は？
製品に基づく市場のブレークアップは？
エンドユーザーに基づく市場のブレークアップは？
業界のバリューチェーンにおける様々なステージは何か？
業界における主要な推進要因と課題は何か？
世界のコレラワクチン市場の構造と主要プレイヤーは？
業界における競争の程度は？

ページTOPに戻る

目次

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Cholera Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Vaccine Type
    6.1    Whole Cell V. Cholerae O1 with Recombinant B-Subunit
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Killed Oral O1 and O139
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Product
    7.1    Dukoral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Shanchol
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Vaxchora
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Euvichol and Euvichol-Plus
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research and Academic Laboratories
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Astellas Pharma Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Emergent BioSolutions Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Eubiologics Co. Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Johnson & Johnson
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Merck & Co. Inc
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Pfizer Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    PharmaChoice Canada Inc
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Takeda Pharmaceutical Company Limited.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Valneva SE
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: Cholera Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cholera Vaccines Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Cholera Vaccines Market: Breakup by Vaccine Type (in %), 2022
Figure 5: Global: Cholera Vaccines Market: Breakup by Product (in %), 2022
Figure 6: Global: Cholera Vaccines Market: Breakup by End User (in %), 2022
Figure 7: Global: Cholera Vaccines Market: Breakup by Region (in %), 2022
Figure 8: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cholera Vaccines (Killed Oral O1 and O139) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cholera Vaccines (Killed Oral O1 and O139) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cholera Vaccines (Dukoral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cholera Vaccines (Dukoral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cholera Vaccines (Shanchol) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cholera Vaccines (Shanchol) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cholera Vaccines (Vaxchora) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cholera Vaccines (Vaxchora) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cholera Vaccines (Other Product) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cholera Vaccines (Other Product) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cholera Vaccines (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cholera Vaccines (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cholera Vaccines (Research and Academic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cholera Vaccines (Research and Academic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cholera Vaccines (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cholera Vaccines (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Cholera Vaccines Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Cholera Vaccines Industry: SWOT Analysis
Figure 78: Global: Cholera Vaccines Industry: Value Chain Analysis
Figure 79: Global: Cholera Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cholera Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cholera Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Cholera Vaccines Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Cholera Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Cholera Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cholera Vaccines Market: Competitive Structure
Table 7: Global: Cholera Vaccines Market: Key Players